Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results PR Newswire - Thu Aug 13, 3:00PM CDT

PALO ALTO, Calif. , Aug. 13, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2026.

KOD : 39.84 (-0.57%)
Kodiak Sciences Reports Earnings as Clinical Momentum Meets Commercial Reality Check Barchart - Tue Aug 11, 4:05PM CDT

Barchart Research What to Expect from KOD Earnings KOD Generated August 11, 2026 Current Price $42.11 EPS Estimate $$-0.97 Consensus Rating Strong Buy Average Move 8.07% Kodiak Sciences Reports Earnings...

KOD : 39.84 (-0.57%)
Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema PR Newswire - Mon Aug 10, 3:43PM CDT

PALO ALTO, Calif. , Aug. 10, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 39.84 (-0.57%)
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 PR Newswire - Thu Aug 6, 6:00AM CDT

PALO ALTO, Calif. , Aug. 6, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD) today announced that it has completed enrollment of the first 300-patient cohort in its PEAK trial, supporting...

KOD : 39.84 (-0.57%)
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference PR Newswire - Thu May 28, 5:09PM CDT

PALO ALTO, Calif. , May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 39.84 (-0.57%)
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results PR Newswire - Thu May 7, 3:00PM CDT

PALO ALTO, Calif. , May 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended March 31, 2026.

KOD : 39.84 (-0.57%)
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences PR Newswire - Thu Apr 30, 11:23PM CDT

PALO ALTO, Calif. , May 1, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 39.84 (-0.57%)
Kodiak Sciences: When Clinical Progress Stops Excusing the Cash Burn Rate Barchart - Wed Apr 1, 4:02PM CDT

Barchart Research What to Expect from KOD Earnings KOD Generated April 1, 2026 Current Price $42.81 EPS Estimate $$-0.86 Consensus Rating Moderate Buy Average Move 7.69% Kodiak Sciences: When Clinical...

KOD : 39.84 (-0.57%)
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results PR Newswire - Tue Mar 31, 3:45PM CDT

PALO ALTO, Calif. , March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended December 31,...

KOD : 39.84 (-0.57%)
Fearless Girl looking up at Wall Street at Night by Tim Pruss via iStock
Stocks Slump on Iran War and Weakness in Chipmakers Barchart - Thu Mar 26, 3:42PM CDT

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.74%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.38%. June...

AMAT : 496.21 (+0.01%)
GOOGL : 340.67 (-1.17%)
MPC : 358.23 (-0.70%)
AAPL : 311.30 (-1.75%)
B : 46.27 (+2.53%)
AVGO : 364.03 (+0.43%)
SNDK : 1,600.62 (+2.02%)
HL : 20.82 (+1.36%)
CDE : 21.11 (+0.86%)
ADI : 370.24 (-0.81%)
BF.B : 28.41 (-0.07%)
$IUXX : 29,213.16 (-0.72%)

Barchart Exclusives

Coatue Management Opens New Position in AMD Stock. View This as a Renewed Bet on the AI Trade. Barchart - 32 minutes ago
Coatue Management started a new AMD stock position worth $55.8 million in Q2, joining a wave of fresh AI bets from the hedge fund giant. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.